Utilities and other high yielding sectors are reaching overbought levels, so investors may want to rotate into biotechs, says TheStreet's Jim Cramer. Cramer said packaged-goods companies and REITs have reached their 'outer-limits' and the money in those areas may gravitate to biotech stocks that have been pressured in the past year. Cramer highlighted a bullish call by RealMoney technical strategist Bruce Kamich on Regeneron (REGN) , saying the stock is poised for a major breakout. Regeneron reports quarterly earnings on Thursday before the open.
More from Video
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.
There is a lot of Apple news to chew on Wednesday.